The governors of Colorado and Hawaii have signed new laws that bar drugmakers from restricting 340B contract pharmacy access and [...] …
Blog Posts
Breaking News
Trump’s Full 2026 Budget Request Would Shift 340B Program from HRSA to CMS, Maintain Current OPA Funding
President Donald Trump’s fiscal year 2026 budget request released yesterday calls for moving control of the 340B program away from [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Vermont legislature has passed a sweeping 340B bill with contract pharmacy protections, provider reporting requirements and controversial price caps [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In the final hours of Oklahoma’s legislative session late last night, lawmakers overwhelmingly voted to override Gov. Kevin Stitt’s (R) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The first published decision under the revamped 340B Administrative Dispute Resolution (ADR) process sided with the drug industry, marking a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient.
…
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …